Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · IEX Real-Time Price · USD
0.690
+0.005 (0.73%)
May 1, 2024, 3:59 PM EDT - Market closed
CDIO Revenue
In the year 2023, Cardio Diagnostics Holdings had annual revenue of $17.07K with 1,696.32% growth. Revenue in the quarter ending December 31, 2023 was $5.31K with 458.95% year-over-year growth.
Revenue (ttm)
$17.07K
Revenue Growth
+1,696.32%
P/S Ratio
883.13
Revenue / Employee
$2,438
Employees
7
Market Cap
15.07M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 17.07K | 16.12K | 1,696.32% |
Dec 31, 2022 | 950.00 | 49.00 | 5.44% |
Dec 31, 2021 | 901.00 | - | - |
Dec 31, 2020 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCDIO News
- 2 days ago - Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually - Business Wire
- 22 days ago - Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan - Business Wire
- 27 days ago - Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre - Business Wire
- 6 weeks ago - Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology's 73rd Annual Scientific Session - Business Wire
- 2 months ago - Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease - Business Wire
- 2 months ago - Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout - Business Wire
- 3 months ago - Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters - Business Wire
- 3 months ago - Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests - Business Wire